TSU-68(SU6668,Orantinib),PDGFR抑制剂

TSU-68 (SU6668, Orantinib) (订货以英文为准)

编号:T125079
CAS号:252916-29-3
分子式:C18H18N2O3
分子量:310.35
货号 品牌 包装 目录价 您的价格 库存 数量 购买
T125079-25mg 阿拉丁 25mg ¥1194.90
T125079-5mg 阿拉丁 5mg ¥385.90
T125079-100mg 阿拉丁 100mg ¥3295.90
T125079-1mg 阿拉丁 1mg ¥159.00
T125079-10mg 阿拉丁 10mg ¥597.90
T125079-50mg 阿拉丁 50mg ¥2059.90
产品名称 TSU-68 (SU6668, Orantinib)
中文名称 TSU-68(SU6668,Orantinib),PDGFR抑制剂
CAS号 252916-29-3
分子式(M.F.) C18H18N2O3
分子量(M.W.) 310.35
储存条件 -20°C储存
沸点590.48° C at 760 mmHg
熔点239.35° C
折光率1.68
溶解性DMSO 62 mg/mL Water <1 mg/mL Ethanol <1 mg/mL
存贮条件储存温度-20°C
密度1.3300
应用An antiproliferating agent and ATP-competitive PDGFR, Flk-1/KDR (VEGF), and FGFR inhibitor
产品介绍TSU-68 (SU6668; Orantinib)是多酪氨酸激酶受体抑制剂,对PDGFR自磷酸化抑制性最强,Ki为8 nM,还能相对弱地抑制VEGF-R1和FGF-R1。
备注SU6668 has greatest potency against PDGFR autophosphorylation with Ki of 8 nM, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit
生化机理TSU-68 (SU6668)is a novel multiple receptor tyrosine kinase inhibitor with IC50 of 2.1 μM, 8 nM and 1.2 μM for VEGF-R1, PDGF-Rβ and FGF-R1, respectively.
别名SU 6668;TSU68; 5-((1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基)-2,4-二甲基-1H-吡咯-3-丙酸;;Orantinib;TSU 68;SU6668; 5-(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-propanoic acid;3-[2,4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid; 3-[2, 4-dimethyl-5-[(E)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl] propanoic acid
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:212141-51-0
¥ 275.90 V125857-10mg
CAS号:905854-02-6
¥ 399.90 T127502-5mg
CAS号:220127-57-1
¥ 29.90 I129225-100mg
CAS号:231277-92-2
¥ 29.90 L126696-25mg
CAS号:257933-82-7
¥ 480.90 P125444-5mg
CAS号:211555-05-4
¥ 1482.90 W125855-10mg
CAS号:928037-13-2
¥ 179.00 E126304-1mg
CAS号:790299-79-5
¥ 844.90 M126981-25mg